- High gross margin of 100.0%
- Excellent financial health (Piotroski 7/9)
- Strong operating margin of 67.9%
Royalty Pharma plc stock price down 0.322% on Friday
(Updated on Jul 24, 2026)
The Royalty Pharma plc stock price fell by -0.322% on the last day (Friday, 24th Jul 2026) from $59.02 to $58.83. During the last trading day the stock fluctuated 2.07% from a day low at $58.51 to a day high of $59.72. The price has risen in 6 of the last 10 days and is up by 4.25% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -46 thousand shares and in total, 2 million shares were bought and sold for approximately $124.36 million.
The stock lies in the upper part of a strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $59.16 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 16.42% during the next 3 months and, with a 90% probability hold a price between $65.48 and $68.87 at the end of this 3-month period.
RPRX Signals & Forecast
The Royalty Pharma plc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $58.43 and $56.20. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 23, 2026, and so far it has fallen -0.322%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Royalty Pharma plc stock
Royalty Pharma plc finds support from accumulated volume at $56.23 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $1.21 (2.07%) between high and low. For the last week, the stock has had daily average volatility of 2.16%.
Our recommended stop-loss: $56.51 (-3.94%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 1 day ago.)
Trading Expectations (RPRX) For The Upcoming Trading Day Of Monday 27th
For the upcoming trading day on Monday, 27th we expect Royalty Pharma plc to open at $59.02, and during the day (based on 14 day Average True Range), to move between $58.16 and $59.50, which gives a possible trading interval of +/-$1.35 (+/-2.32%) up or down from last closing price. If Royalty Pharma plc takes out the full calculated possible swing range there will be an estimated 2.32% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $59.02 (0.32%) than the support at $56.23 (4.42%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Dividend Warning For RPRX
Dividend coming up for RPRX: Ex-dividend date (Friday 14th August, 2026) is 19 days away. The dividend is $0.240.Is Royalty Pharma plc stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Royalty Pharma plc stock to perform well in the short-term.
Current score:
4.131
Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on July 27, 2026 - $59.02 ( 0.323%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
RPRX Performance
Trading levels for RPRX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 60.23 | 2.38% |
| R2 | 59.77 | 1.59% |
| R1 | 59.48 | 1.11% |
| Price | 58.83 | |
| S1 | 58.56 | -0.463% |
| S2 | 58.27 | -0.95% |
| S3 | 57.81 | -1.73% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 59.02 | 0.323% |
| Price | 58.83 | |
| S1 | 56.23 | -4.42% |
| S2 | 55.76 | -5.22% |
| S3 | 52.96 | -9.98% |
RPRX Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Jul 17, 2026 | Aug 14, 2026 | Sep 10, 2026 | $0.235 | 0.400% |
| 2 | Apr 17, 2026 | May 15, 2026 | Jun 10, 2026 | $0.235 | 0.477% |
| 3 | Jan 09, 2026 | Feb 20, 2026 | Mar 10, 2026 | $0.235 | 0.584% |
| 4 | Oct 17, 2025 | Nov 14, 2025 | Dec 10, 2025 | $0.220 | 0.601% |
| 5 | Jul 18, 2025 | Aug 15, 2025 | Sep 10, 2025 | $0.220 | 0.617% |
FAQ
Click here for our free guide on how to buy Royalty Pharma plc Stock.
Buy RPRX